Genomics

Dataset Information

0

Large-scale genomic alterations identified in cancer patients on the course of cancer recovery with complementary Huaier treatment identified by total RNA- and small non-coding RNA-sequencing.

ABSTRACT: Large-scale genomic alterations identified in cancer patients on the course of cancer recovery with complementary Huaier treatment identified by total RNA- and small non-coding RNA-sequencing.

PROVIDER: PRJNA660034 | ENA |

REPOSITORIES: ENA

Json Xml

Dataset's files

Source:
Action DRS
SRR12541600.fastq.gz Fastqsanger.gz
SRR12541601.fastq.gz Fastqsanger.gz
SRR12541602.fastq.gz Fastqsanger.gz
SRR12541603.fastq.gz Fastqsanger.gz
SRR12541604.fastq.gz Fastqsanger.gz
Items per page:
1 - 5 of 184

Similar Datasets

Transcriptomics Large-scale genomic alterations identified in cancer patients on the course of cancer recovery with complementary Huaier treatment identified by total RNA- and small non-coding RNA-sequencing.
2021-09-01 | GSE157086 | GEO
Transcriptomics Huaier Enhances the Antitumor Activities of Black Phosphorus and Alleviates Nephrotoxicity by Regulating Mitophagy and Autophagy
2023-08-01 | GSE229091 | GEO
Genomics Moringa oleifera concentrate as a complementary treatment in triple negative breast cancer
| PRJNA741777 | ENA
Genomics Endogenous viral elements constitute a complementary source of antigens for personalized cancer immunotherapy
| PRJNA926630 | ENA
Genomics Circular RNA hsa_circ_0064559 is identified to affect the progression of colorectal cancer
| PRJNA862888 | ENA
Genomics Complementary Alu sequences mediate enhancer-promoter selectivity
| PRJNA786348 | ENA
Genomics Circular RNA hsa_circ_0064559 is identified to affect the progression of colorectal cancer [PrimeView]
| PRJNA940427 | ENA
Genomics Cancer-Selective Mechanistic Targets of Diallyl Trisulfide (DATS) in Human Breast Cancer Cells Identified by RNA-seq Analysis
| PRJNA827109 | ENA
Genomics ChAHP and ChAHP2 control diverse retrotransposons by complementary activities [RNA-seq]
| PRJNA1063745 | ENA
Genomics CRISPR-Cas9 directed modelling of estrogen receptor mutations identified in breast cancer
| PRJNA616301 | ENA